Expedite time to market with the fastest and easiest IgG quantification assay in the industry
The ability to reliably monitor protein titer in real time throughout a bioprocess allows operators to rapidly adjust the process conditions for maximum protein output while minimizing process time. Quick access to titer data also enables earlier decisions regarding preparation of downstream processes, further reducing the production timeline.
Integrating ValitaTiter and Molecular Devices fluorescence polarization (FP) plate readers produces a seamless IgG titer assay setup and optimization. Cell line development teams will realize savings on time and resources, as well as faster time-to-market by utilizing a single technology for measuring a critical quality attribute during target selection, process development, and production QC.
Producing rapid results compared to HPLC, ELISA, and biolayer interferometry, ValitaTiter is the most efficient assay for minimizing costs and time to results because it works in the presence of cells, minimizes dilutions, eliminates wash steps, and easily integrates into (automated) high-throughput cell line development (CLD) workflows.
Valita and Valita Titer are trademarks of ValitaCell in certain jurisdictions
Resources of Rapid, high-throughput IgG quantification with ValitaTiter
Biologic drugs are the largest and fastest growing segment of the pharmaceutical industry with sales of €500bn and an annual growth of 8%. Every manufacturing process for potential b…
Biologic drugs are the largest and fastest growing segment of the pharmaceutical industry with sales of €500bn and an annual growth of 8%. Every manufacturing process for potential…
The process of cell line development for the production of antibody-based therapeutics can vary widely amongst researchers. The ultimate goal is to find a clone that stably produces…
High-throughput IgG quantitation platform for clone screening during drug discovery and development